Nucleate SD: Inside Licensing and Tech Transfer
Join us to explore the core principles that govern licensing and technology transfer within the biotech industry, including how academic inventions are evaluated, protected, and ultimately advanced through development and commercialization pathways
Our panelists will guide a conversation outlining the end-to-end technology transfer pathway - from invention disclosure and patenting decisions through license negotiation and post-license obligations, and discuss the key structures that shape these agreements. The session will emphasize practical considerations for early-stage teams seeking to align scientific development, institutional requirements, and future financing or partnering.
Panelists: Tali Tuchin, Marc Morley, and Paul Roben
Our panel will be followed by an unstructured networking hour from 7:00 - 8:00 pm.
We would like to thank Mintz for hosting this event!
About the Host:
Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.xyz for more information, and visit https://nucleate.xyz/privacy-policy/ to read our privacy policy.
We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!
Platinum: Eli Lilly and Company, Genentech, Alnylam Pharmaceuticals, MilliporeSigma
Philanthropic Support: Lyda Hill Philanthropies
Preferred Partners: Pillar VC, Amino Collective, Excedr, Mercury, Brex, Fedsprout
In-Kind Support: AcademicLabs, Lens.org, SynBioBeta